Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 7,944 | 53 | 9 | 2,050 |
| Gross Profit | 0 | 7,944 | 53 | 9 | 2,050 |
| Operating Expenses | 1,652 | 5,947 | 2,417 | 4,350 | 6,643 |
| Operating Income | -1,652 | 1,997 | -2,364 | -4,341 | -4,593 |
| Interest Expense | 0 | 0 | 2 | 3 | 3 |
| Other Income | 414 | 107 | 82 | 68 | 69 |
| Pre-tax Income | -1,238 | 2,104 | -2,284 | -4,276 | -4,527 |
| Net Income Continuous | -1,238 | 2,104 | -2,284 | -4,276 | -4,527 |
| Net Income | $-1,238 | $2,104 | $-2,284 | $-4,276 | $-4,527 |
| EPS Basic Total Ops | 0.15 | 0.32 | -0.39 | -1.14 | -1.46 |
| EPS Basic Continuous Ops | 0.11 | 0.36 | -0.39 | -1.14 | -1.47 |
| EPS Diluted Total Ops | 0.15 | 0.32 | -0.39 | -1.14 | -1.46 |
| EPS Diluted Continuous Ops | 0.11 | 0.36 | -0.39 | -1.14 | -1.47 |
| EPS Diluted Before Non-Recurring Items | -0.20 | 0.32 | -0.39 | -1.14 | -1.50 |
| EBITDA(a) | $-1,642 | $2,008 | $-2,354 | $-4,331 | $-4,584 |